Pipeline — registered trials by phase
Community-based Program to Treat Childhood Obesity
— · Childhood Obesity · Completed · est. 2012-06-05
Evaluation of Video On-Demand Programming to Prevent Type 2 Diabetes in Adults
— · Pre-diabetes · Completed · est. 2013-05
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
— · SARS-CoV Infection · Completed · est. 2020-08-18
Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care
— · PreDiabetes, Diabetes Mellitus, Type 2 · Completed · est. 2021-10-26
Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals
— · Infections, Respiratory, Fever, Cough · Completed · est. 2020-03-23
Evaluation of a Commercial Gaming Impact in a Childhood Obesity Intervention
— · Childhood Obesity · Completed · est. 2012-09
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where UnitedHealth is lead sponsor; 6 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-08Current report (material event)
- 10-Q2026-08-10Quarterly report
- SCHEDULE 13G2026-08-07SCHEDULE 13G
- 8-K2026-07-16Current report (material event)
- 11-K2026-06-1111-K
- 8-K2026-06-05Current report (material event)
- DEFA14A2026-05-15DEFA14A
- 8-K2026-05-11Current report (material event)
- 10-Q2026-05-05Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- DEFA14A2026-04-21DEFA14A
- DEF 14A2026-04-21Proxy statement
- 8-K2026-04-21Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-09Current report (material event)
- S-3ASR2026-03-02S-3ASR
- 8-K2026-03-02Current report (material event)
- 10-K2026-03-02Annual report
- 8-K2026-02-25Current report (material event)
- 8-K2026-01-27Current report (material event)
- 8-K2026-01-12Current report (material event)
- 8-K2025-11-21Current report (material event)
- 8-K2025-11-13Current report (material event)
- S-82025-11-13Employee stock plan
- 8-K2025-11-07Current report (material event)
- 10-Q2025-10-28Quarterly report
- 8-K2025-10-28Current report (material event)
- 8-K/A2025-09-09Current report (amended)
- 8-K2025-09-08Current report (material event)
- 8-K2025-08-20Current report (material event)
- S-82025-08-14Employee stock plan
- 10-Q2025-08-11Quarterly report
- 8-K2025-07-31Current report (material event)
- 8-K2025-07-29Current report (material event)
- 8-K2025-07-24Current report (material event)
- 8-K2025-06-20Current report (material event)
- 424B52025-06-18Prospectus (offering)
- FWP2025-06-17FWP
- 424B52025-06-17Prospectus (offering)
- 11-K2025-06-1311-K
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.